Replies to post #2678 on Nascent Biotech Inc. (NBIO)

[BlazingStocks]

Power Hour approaches and we'll see if this can break 0.058.

$NBIO - About Nascent Biotech

Nascent Biotech, Inc. is a clinical-stage biotech company pioneering the development of monoclonal antibodies to be used in the treatment of various cancers and viral infections, helping people worldwide. Its products are not yet commercially available. The Company's lead candidate, Pritumumab (PTB), is a monoclonal Antibody (Mab) that is being studied in Phase I clinical trials for the treatment of Brain Cancer.